*Department of Ophthalmology and Visual Sciences, Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY; †New York Structural Genomics Research Consortium, Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY; ‡Henan Eye Institute, Zhengzhou, China; §Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD; ¶King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; and ‖Department of Ophthalmology, The First Teaching Hospital, Zhengzhou University, Zhengzhou, China.
Cornea. 2014 Mar;33(3):288-93. doi: 10.1097/ICO.0000000000000055.
The aim of this study was to characterize the congenital stromal corneal dystrophy (CSCD) pathological and clinical phenotype in a Chinese family with a novel mutation of decorin and its possible molecular pathogenesis.
Molecular genetic analyses were performed on 5 patients with CSCD. Clinical characteristics, optical coherence tomography, and confocal microscopic study were evaluated. The corneal specimens from patients with CSCD were sent for light and electron microscopic evaluation. A protein modeling study was carried out to assess the effect of the mutation on the protein structure.
Sequencing analysis of DCN revealed that all patients with CSCD were heterozygous for a 1-bp deletion at nucleotide 962 (c.962delA) in exon 8. This causes a premature termination of the decorin protein by frameshift, causing the deletion of 33 amino acids in the C-terminal end of the decorin protein. Optical coherence tomography and confocal microscopic study demonstrated that the corneal lamellar structure was disrupted and that this is more severe in the anterior and posterior central stroma. Histopathological study showed that electron-lucent zones were present between the normal-appearing collagen lamellae in the patients with CSCD. Abnormally thinned collagen filaments were identified in the electron-lucent zones, which could be due to abnormal decorin binding to the collagen microfibrils. Protein modeling studies involving wild-type and mutant protein indicated that mutant decorin might be unable to bind to all 4 collagen microfibrils as the normal decorin would.
We present the clinical, histopathological, and molecular genetic assessment of a Chinese family with CSCD in which a novel DCN mutation was identified. Our findings add to the allelic heterogeneity of this rare form of inherited corneal disease.
本研究旨在对一个中国家庭中新型核心蛋白聚糖(decorin)突变所致先天性基质性角膜营养不良(CSCD)的病理和临床表型进行特征描述,并探讨其可能的分子发病机制。
对 5 名 CSCD 患者进行分子遗传学分析。评估临床特征、光学相干断层扫描和共聚焦显微镜检查。将 CSCD 患者的角膜标本送检行光镜和电镜评估。进行蛋白建模研究以评估突变对蛋白结构的影响。
DCN 测序分析显示,所有 CSCD 患者均为第 8 外显子 962 位核苷酸(c.962delA)处的 1 个碱基缺失杂合子。该突变导致核心蛋白聚糖蛋白的移码提前终止,导致核心蛋白聚糖蛋白 C 末端的 33 个氨基酸缺失。光学相干断层扫描和共聚焦显微镜检查显示,角膜板层结构中断,前、后中央基质更为严重。组织病理学研究显示 CSCD 患者的胶原板层之间存在电子透明区。在电子透明区中发现异常变薄的胶原丝,这可能是由于异常的核心蛋白聚糖与胶原微纤维结合所致。涉及野生型和突变型蛋白的蛋白建模研究表明,突变型核心蛋白聚糖可能无法像正常核心蛋白聚糖那样与所有 4 根胶原微纤维结合。
我们对一个中国 CSCD 家系进行了临床、组织病理学和分子遗传学评估,该家系中发现了一种新型 DCN 突变。我们的研究结果增加了这种罕见遗传性角膜疾病的等位基因异质性。